Asia emerging as a hub for global pharmaceutical industry
Jones Lang LaSalle report sees life sciences sector place greater emphasis on Asia as a market, manufacturing and R&D location SINGAPORE, 6 February 2013 – Pharmaceutical multinationals are reinforcing their presence in Asia, according to Jones Lang LaSalle’s latest Global Life Sciences Cluster Report. Widening patient pools and increasing consumer demand in emerging markets is …